Relay Therapeutics, Inc. — Director's Dealing 2021

Mar 25, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Relay Therapeutics, Inc. (RLAY)
CIK: 0001812364
Period of Report: 2021-03-11

Reporting Person: Borisy Alexis (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-11	Common Stock	J	28538	$0.00	Acquired	234175	Direct

Footnotes

F1: Pro rata distribution from Third Rock Ventures GP III, L.P., of which the reporting person is a limited partner.